CanSino Biologics Inc (CJH) — Cash Flow Quality Index
CanSino Biologics Inc (CJH) has a Cash Flow Quality Index of -4.93x as of March 2022. Operating cash flow of €-598.15 Million is below net income of €121.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore CJH total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CanSino Biologics Inc Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CanSino Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CJH tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CanSino Biologics Inc (2021–2025)
Year-by-year earnings quality comparison for CanSino Biologics Inc. For live market cap and the full company financial profile, see CJH market cap.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.79x | €77.86 Million | €27.87 Million | ▲ +160.8% |
| 2021 | 1.07x | €2.05 Billion | €1.91 Billion | — |